Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?

Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?

Bibliographic Details
Main Authors:	Jaydeep Bhat, Léonce Kouakanou, Christian Peters, Zhinan Yin, Dieter Kabelitz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-03-01
Series:	Frontiers in Immunology
Subjects:	Bromodomain and ExtraTerminal domain checkpoint inhibitors DNA methylation gamma delta T cells histone acetylation immunotherapy
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/full

Similar Items

Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor Cancers
by: Martin V. Nguyen, et al.
Published: (2020-02-01)

Histone Acetylation and Modifiers in Renal Fibrosis
by: Fengchen Shen, et al.
Published: (2022-04-01)

Bromodomain inhibitors and cancer therapy: From structures to applications
by: Montserrat Pérez-Salvia, et al.
Published: (2017-05-01)

Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
by: Jaydeep Bhat, et al.
Published: (2019-03-01)

Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma
by: Yuting Meng, et al.
Published: (2021-04-01)

BRD4: An emerging prospective therapeutic target in glioma
by: Hua Yang, et al.
Published: (2021-06-01)

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
by: Rosemarie Tremblay-LeMay, et al.
Published: (2018-03-01)

The Functions of BET Proteins in Gene Transcription of Biology and Diseases
by: Ka Lung Cheung, et al.
Published: (2021-09-01)

BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
by: Jessica Sriha, et al.
Published: (2022-06-01)

Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy
by: Jaydeep Bhat, et al.
Published: (2022-05-01)

Pharmacological Modulation of BET Family in Sepsis
by: Nian Wang, et al.
Published: (2021-03-01)

TGF-β enhances the cytotoxic activity of Vδ2 T cells
by: Christian Peters, et al.
Published: (2019-01-01)

Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
by: Monika Krošel, et al.
Published: (2023-04-01)

Recent advances in gamma/delta T cell biology: new ligands, new functions, and new translational perspectives
by: Dieter eKabelitz, et al.
Published: (2015-07-01)

Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy via Regulating the Expression of Citrate Cycle Genes
by: Zhirong Lin, et al.
Published: (2022-05-01)

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
by: Kenneth K. W. To, et al.
Published: (2023-03-01)

Two bromodomain proteins functionally interact to recapitulate an essential BRDT-like function in Drosophila spermatocytes
by: Shuhei Kimura, et al.
Published: (2015-01-01)

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials
by: Yanli Sun, et al.
Published: (2021-01-01)

Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers
by: Juliana Romano Lopes, et al.
Published: (2021-12-01)

Natural Self-Ligand Gamma Delta T Cell Receptors (γδTCRs) Insight: The Potential of Induced IgG
by: Thamires Rodrigues de Sousa, et al.
Published: (2020-08-01)

Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic Cancer
by: Feda H. Hamdan, et al.
Published: (2018-05-01)

Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells
by: Yuki Kotani, et al.
Published: (2024-03-01)

Human gamma delta T regulatory cells in cancer: fact or fiction?
by: Daniela eWesch, et al.
Published: (2014-11-01)

Kinetic proofreading of chromatin remodeling: from gene activation to gene repression and back
by: Raghvendra P Singh, et al.
Published: (2015-08-01)

CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
by: Aaron R. Waddell, et al.
Published: (2021-06-01)

Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer
by: Aaron Waddell, et al.
Published: (2021-06-01)

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease
by: Katiri J. Snyder, et al.
Published: (2021-10-01)

Chemical probes targeting epigenetic proteins: Applications beyond oncology
by: Suzanne Ackloo, et al.
Published: (2017-05-01)

Nucleosome conformation dictates the histone code
by: Matthew R Marunde, et al.
Published: (2024-02-01)

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
by: Yu Meng, et al.
Published: (2023-12-01)

Editorial: Next generation γδ T cell-based tumor immunotherapy
by: Andy Hee-Meng Tan, et al.
Published: (2022-09-01)

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells
by: Christopher D. Sarsons, et al.
Published: (2023-09-01)

Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation
by: Archit Trivedi, et al.
Published: (2020-03-01)

Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins
by: Jiacheng Lai, et al.
Published: (2021-09-01)

Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins
by: Li Junlin, et al.
Published: (2013-02-01)

Epigenetics in ovarian cancer: premise, properties, and perspectives
by: Qilian Yang, et al.
Published: (2018-07-01)

The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
by: Eline van Diest, et al.
Published: (2023-01-01)

Exploring Transcriptional Regulation of Beta Cell SASP by Brd4-Associated Proteins and Cell Cycle Control Protein p21
by: Jasmine Manji, et al.
Published: (2024-03-01)

Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer
by: Krishan Kumar, et al.
Published: (2023-05-01)

Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas
by: Ibrahim N. Muhsen, et al.
Published: (2022-06-01)